These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36824609)

  • 1. Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling.
    Zhang J; Wu K; Liu B; Hou S; Li X; Ye X; Liu J; He Q
    Front Med (Lausanne); 2023; 10():1056318. PubMed ID: 36824609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculating the Charcoal Blockade Efficiency for Bioequivalence Study of Inhaled Ipratropium Bromide Using A Model Method.
    Cheng Y; Zhou X; Wang Z; He G; Yang L; Hou S
    J Pharm Sci; 2022 Jul; 111(7):2107-2115. PubMed ID: 35257696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the predictive capability of modelling and simulation to determine bioequivalence of inhaled drugs: A systematic review.
    Rebello J; Brashier B; Shukla S
    Daru; 2022 Jun; 30(1):229-243. PubMed ID: 35094370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pharmacokinetic parameters of inhaled indacaterol formulation in healthy volunteers using physiologically-based pharmacokinetic (PBPK) model.
    Tang C; Ou-Yang CX; Chen WJ; Zou C; Huang J; Cui C; Yang S; Guo C; Yang XY; Lin Y; Pei Q; Yang GP
    Eur J Pharm Sci; 2022 Jan; 168():106055. PubMed ID: 34742834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting bioequivalence and developing dissolution bioequivalence safe space in vitro for warfarin using a Physiologically-Based pharmacokinetic absorption model.
    Cheng ZZ; Hu X; Li YL; Zhang L
    Eur J Pharm Biopharm; 2023 Oct; 191():12-25. PubMed ID: 37567396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Regional Respiratory Tissue and Systemic Concentrations of Orally Inhaled Drugs through a Novel PBPK Model.
    Ladumor MK; Unadkat JD
    Drug Metab Dispos; 2022 May; 50(5):519-528. PubMed ID: 35246463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico prediction of bioequivalence of Isosorbide Mononitrate tablets with different dissolution profiles using PBPK modeling and simulation.
    Zhang F; Zhou Y; Wu N; Jia R; Liu A; Liu B; Zhou Z; Hu H; Han Z; Ye X; Ding Y; He Q; Wang H
    Eur J Pharm Sci; 2021 Feb; 157():105618. PubMed ID: 33122011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a Physiologically Based Pharmacokinetic Absorption Model to Establish Dissolution Bioequivalence Safe Space for Oseltamivir in Adult and Pediatric Populations.
    Miao L; Mousa YM; Zhao L; Raines K; Seo P; Wu F
    AAPS J; 2020 Aug; 22(5):107. PubMed ID: 32779046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence assessment of pharmaceutical aerosol products through IVIVC.
    Sandell D
    Adv Drug Deliv Rev; 2021 Sep; 176():113895. PubMed ID: 34329687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle size and gastrointestinal absorption influence tiotropium pharmacokinetics: a pilot bioequivalence study of PUR0200 and Spiriva HandiHaler.
    Perry J; Trautman B; Takher-Smith J; Kramer S; Kane K; Silverman M; Tan L; Haughie S; Richter W; Kirkov V; Arsova S; Ward J; Hava DL
    Br J Clin Pharmacol; 2019 Mar; 85(3):580-589. PubMed ID: 30521129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconvolution of Systemic Pharmacokinetics Predicts Inhaled Aerosol Dosimetry of Nicotine.
    Kolli AR; Calvino-Martin F; Kuczaj AK; Wong ET; Titz B; Xiang Y; Lebrun S; Schlage WK; Vanscheeuwijck P; Hoeng J
    Eur J Pharm Sci; 2023 Jan; 180():106321. PubMed ID: 36336278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption.
    Miller NA; Graves RH; Edwards CD; Amour A; Taylor E; Robb O; O'Brien B; Patel A; Harrell AW; Hessel EM
    Clin Pharmacokinet; 2022 Feb; 61(2):281-293. PubMed ID: 34458976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms.
    Boger E; Fridén M
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets.
    Shuklinova O; Wyszogrodzka-Gaweł G; Baran E; Lisowski B; Wiśniowska B; Dorożyński P; Kulinowski P; Polak S
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products.
    Ibarra M; Valiante C; Sopeña P; Schiavo A; Lorier M; Vázquez M; Fagiolino P
    Eur J Pharm Sci; 2018 Jun; 118():176-182. PubMed ID: 29605455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a clinically relevant specification for dissolution testing using physiologically based pharmacokinetic (PBPK) modeling approaches.
    Kato T; Nakagawa H; Mikkaichi T; Miyano T; Matsumoto Y; Ando S
    Eur J Pharm Biopharm; 2020 Jun; 151():45-52. PubMed ID: 32298756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetic modelling to guide drug delivery in older people.
    Chetty M; Johnson TN; Polak S; Salem F; Doki K; Rostami-Hodjegan A
    Adv Drug Deliv Rev; 2018 Oct; 135():85-96. PubMed ID: 30189273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic physiologically based model to assess the effect of study design and modified physiology on formulation safe space for virtual bioequivalence of dermatological drug products.
    Clarke JF; Thakur K; Polak S
    Front Pharmacol; 2022; 13():1007496. PubMed ID: 36532731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Same lung deposited dose in dog dosing a fine and coarse aerosol indicates no difference in intranasal filtration.
    Brülls M; Oag S; Karlsson CA; Lamm Bergström E
    Int J Pharm; 2022 Aug; 624():121977. PubMed ID: 35792234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.